The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series

摘要

Background Evidence on the role of plasma exchange for treating recurrent post-transplant focal segmental glomerulosclerosis (FSGS) comes largely from individual cases and uncontrolled series. We conducted a systematic review and meta-analysis to estimate the remission rate after treatment with plasma exchange, and to determine if remission varied with patient or treatment characteristics. Methods We searched MEDLINE, EMBASE, Science Citation Index Expanded, and the Conference Proceedings Citation Index (Science and BIOSIS) for studies of patients with post-transplant recurrent FSGS who were treated with plasma exchange after recurrence (1950–2012). Of 678 studies screened, 77 met our inclusion criteria: 34 case reports (45 patients) and 43 case series (378 patients). We extracted patient-level data from each study and used random-effects models to calculate remission, defined as proteinuria Results The overall remission rate in 423 patients with outcome data was 71?% (95?% CI: 66?% to 75?%). In 235 patients with data on age, remission was similar for adults and children: 69.1?% (95?% CI: 59.6?% to 77.2?%) and 70.2?% (95?% CI: 61.1?% to 77.9?%). Males were more likely to achieve remission (OR?=?2.85; 95?% CI: 1.44 to 5.62) and patients treated within 2?weeks of recurrence showed a trend towards higher likelihood of remission (OR?=?2.16; 95?% CI: 0.93 to 5.01). Proteinuria >7?g/day at recurrence was inversely associated with remission (OR?=?0.43; 95?% CI: 0.19 to 0.97). Age and type of kidney transplant (living vs. deceased) did not associate with remission. Conclusion In this systematic review of patients with recurrent post-transplant FSGS, 71?% of patients achieved full or partial remission after treatment with plasma exchange; however, extensive missing data and lack of a control group limit any conclusions on causality.